Doctor profile · Federal record
Dr. LYNNE PERRY-BOTTINGER, M.D.
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Interventional Cardiology Physician · NEW ROCHELLE, NY
- NPI 1568448314
- Accepts Medicare
- 40 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
140A LOCKWOOD AVE
NEW ROCHELLE, NY 108014920
(914) 576-7577
fax (914) 576-7377 - Mailing address
-
140A LOCKWOOD AVENUE
NEW ROCHELLE, NY 108014920
Credentials & registration
- NPI registered
- December 2005 — 21 yrs on file
- Profile last updated
- December 3, 2025
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- New York #206637
- Medicaid
- NY #01741120
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568448314. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
482
Distinct HCPCS
6
Medicare allowed
$45,500
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 222 | 188 | $17 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 146 | 135 | $149 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 71 | 69 | $207 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 16 | 14 | $105 | |
93246 |
Heart rhythm recording of continous external ekg over 8-15 days | 14 | 14 | $15 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 13 | 13 | $257 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 132. This provider delivers 3.7× the peer median.Open Payments
Industry payments received
All-time total
$2,009
Transactions
31
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $773.04 | |
| Kiniksa Pharmaceuticals International, plc | 2 | $250.00 | |
| Abbott Laboratories | 2 | $170.39 | |
| Amgen Inc. | 1 | $150.00 | |
| Novo Nordisk Inc | 2 | $145.15 | |
| Lilly USA, LLC | 2 | $140.71 | |
| Actelion Pharmaceuticals US, Inc. | 3 | $109.38 | |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $65.60 | |
| Esperion Therapeutics, Inc. | 3 | $62.14 | |
| PFIZER INC. | 2 | $56.32 | |
| SCPHARMACEUTICALS INC. | 1 | $51.65 | |
| Merck Sharp & Dohme LLC | 1 | $18.09 | |
| Kowa Pharmaceuticals America, Inc. | 1 | $16.38 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,912
Patients
652
Total drug cost
$141,510
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Amlodipine Besylate | Generic | 265 | 82 | $2,149 |
| Rosuvastatin Calcium | Generic | 241 | 84 | $4,867 |
| Atorvastatin Calcium | Generic | 214 | 74 | $3,282 |
| Metoprolol Succinate | Generic | 201 | 65 | $4,171 |
| Losartan Potassium | Generic | 179 | 59 | $1,789 |
| Ezetimibe | Generic | 161 | 56 | $9,339 |
| Hydrochlorothiazide | Generic | 103 | 38 | $412 |
| Furosemide | Generic | 84 | 37 | $505 |
| Simvastatin | Generic | 81 | 24 | $824 |
| Pravastatin Sodium | Generic | 72 | 27 | $1,246 |